Anti-Cancer Cyclodextrin Nanocapsules Based Formulation Development for Lung Chemotherapy

Lung carcinoma is one of the highly malignant carcinoma. Oncologists also face a difficulty in handling lung carcinoma. A novel therapeutically strategy in patients with pulmonary cancer may be the immediate injection of chemical-therapeutic agents within lungs. Many drugs are available for in market for treatment of lung cancer but face difficulty due to poor solubility. The paper discusses about development of cyclodextrin modified cationic polymer complex i.e. polyethylene glycol (PEG), wherein the complex is used for providing drug delivery of poorly soluble drugs, more specifically ellipcitine. The complex was made by coating PEG over cyclodextrin nanocapsules wherein the core of the capsule is filled with PEG-7 Glyceryl Cocoate oil for enhancing the delivery of the anti-cancer agent. The complex was then evaluated under characterization studies which includes particle size analysis, zeta potential, morphological analysis, cytotoxicity analysis and anti-cancer effect of the complex. It was found that the complex was more potent in delivering the drug within cancerous cells and was potent to treat lung carcinoma.